Related Experiment Video
Updated: Oct 17, 2026

Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Published on: September 28, 2022
An integrated evolutionary optimization and machine learning framework for predicting pharmacokinetics of
1Pharmaceutical Science Department, College of Pharmacy, Umm Al Qura University, Makkah, Saudi Arabia.
Abstract:
This study developed a machine learning framework for predicting the pharmacokinetic behavior of nanocarrier systems using integrated molecular, physicochemical, and formulation descriptors. A Multilayer Perceptron Regressor (MLPR) was employed as the baseline predictive model, while evolutionary optimization algorithms were used to optimize the neural-network architecture and training parameters. The framework was evaluated for predicting three pharmacokinetic endpoints: maximum concentration (Cmax), time to maximum concentration (Tmax), and area under the concentration-time curve (AUC). The combined model produced 20%-30% reductions in RMSE for Cmax and AUC and kept R 2 values above 0.85, while Tmax remained comparatively more challenging to model than Cmax and AUC, reflecting the stronger influence of dynamic absorption and release-related processes on temporal pharmacokinetic behavior. The results demonstrate that optimizer-guided neural-network tuning can improve pharmacokinetic prediction from heterogeneous nanocarrier datasets. The proposed framework provides an approach for improving the prediction of Cmax, Tmax, and AUC while explicitly considering predictive uncertainty and computational trade-offs.
Related Concept Videos
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Analysis of Population Pharmacokinetic Data
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
